(Reuters) – The U.S. Food and Drug Administration has cleared Abbott Laboratories’ blood test that helps doctors to evaluate patients with mild traumatic brain injury, known as concussion, the company said on Tuesday.
(Reporting by Raghav Mahobe in Bengaluru)
